Sensei Biotherapeutics
SNSE
SNSE
20 hedge funds and large institutions have $760K invested in Sensei Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$16.8K |
| 2 |
Renaissance Technologies
New York
|
+$8.08K |
| 3 |
Barclays
London,
United Kingdom
|
+$1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$717 |
| 5 |
Citigroup
New York
|
+$49 |
Top Sellers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$78.8K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$30.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$28.3K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$25.3K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$23.5K |